# Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors

> **NCT01663363** · PHASE3 · COMPLETED · sponsor: **Abbott Medical Optics** · enrollment: 170 (actual)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** LASIK correction of myopic refractive errors

## Key facts

- **NCT ID:** NCT01663363
- **Lead sponsor:** Abbott Medical Optics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-03
- **Final completion:** 2015-07
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01663363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01663363, "Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01663363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*